SURVEY for the Center for Devices and Radiological Health (CDRH) at FDA

Can you help? Please take this 10 minute Survey.

The Center for Devices and Radiological Health (CDRH) at FDA are pleased to collaborate with several patient advocacy organizations such as the American Sleep Apnea Association (ASAA), as a way for patients and caregivers to share their experiences with disease conditions and the use of medical devices for their diagnosis and treatment.  CDRH's ability to evaluate medical devices and monitor their safety is optimized by the valuable feedback and information that patients and caregivers like you can provide, and we appreciate any information that you are willing to share with us.

This pilot survey is being distributed to members of ASAA such as yourself so that you can share your perceptions living with or caring for those with a specific disease, your experience with medical devices, and any related issues that are important to you.  This information will help us to gain a better understanding of the patient and caregiver experience and identify areas of concern.

We thank you for your time in answering our questions. Your responses to this survey will remain anonymous. Once complete, the survey results will be shared with your organization.

Please know that this survey and its individual questions are voluntary and you may leave any questions blank that you don’t wish to answer.

​

Many thanks in advance for your participation.

DBSA Well beyond Blue initiative: Meeting & Survey

Depression is often part of the journey for Sleep Apnea patients, adding even more challenges to a difficult path. The ASAA is partnering with the Depression and Bipolar Support Alliance to help FDA and life science companies understand what’s most important to every person living with depression. Be part of this joint effort by responding to the “Supporting Wellness” survey.

Since going live on August 1, 2018 the survey has received over 4,500 responses to this first-ever peer designed survey that enables respondents to share views on wellness as well as, identify research priorities.

Please register to attend the DBSA-led Patient-Focused Medical Product Development Meeting on November 16, 2018. Our collective voices are needed in-person at this meeting which will be held near the FDA campus in Silver Spring, MD. This meeting will empower people living with depression and/or bipolar to share their personal views on aspects of wellness and name the wellness strategies that work best for them. For those who live farther out, they can participate via live stream.
Please register to attend either in person - or online here.

www.DBSAlliance.org/WellBeyondBlue